Home Therapeutics Cardiovascular Drugs

Cardiovascular Drugs

    Latest
    Mutations in the gene APOC3 lower triglyceride levels in the blood and also significantly reduce a person's risk of coronary heart disease. [Susanna Hamilton
    Cardiovascular Drugs

    Prescribing the Right Blood Thinner May Pivot on a Genetic Test

    Vein Atherosclerotic Plaque
    Cardiovascular Drugs

    Preclinical Study Shows Safety, Efficacy, and Durability of Lowering LDL-Cholesterol Levels...

    3d illustration of a part of RNA chain from which the deoxyribonucleic acid or DNA is composed
    Cardiovascular Drugs

    RNA in Its DNA: Avidity Biosciences Combines mAb Selectivity, Oligonucleotide Precision

    Cardiovascular Drugs

    Bayer Approach to Partnerships, Pipelines, and Platforms

    Cardiovascular Drugs

    Bristol-Myers Squibb to Acquire MyoKardia for $13.1B, Expanding Cardiovascular Franchise

    Cardiovascular Drugs

    Old, Leaky Blood Vessels Modeled via Direct Reprogramming of Skin Cells

    Vein Atherosclerotic Plaque
    Cardiovascular Drugs

    Heart Disease Therapeutics Could Arise from Newly Discovered Mutation

    Cardiovascular Drugs

    Gut Microbiome Potentially Improved by Statin Therapy

    Cardiovascular Drugs

    Fight-or-Flight Time? That’s When Calcium Channels Give Up Rad

    Cardiovascular Drugs

    Pfizer to Develop Akcea/Ionis Antisense Candidate for Up to $1.5B

    123...6Page 1 of 6
    Copyright © 2022 Genetic Engineering & Biotechnology News. All Rights Reserved.